Jacob Caylor, MD
Interventional Pain Medicine · Cedar Park, TXNPI 1013370717
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 80.4% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2023 at $38,263 and has fallen 91.2% since, to $3,365 in 2025. Among interventional pain medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 640 payments — averaging $154.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$80K
- Boston Scientific$7K
- Abbott$5K
- Globus Medical$2K
- Nevro Corp.$1K
- Nalu Medical, Inc.$950
- plus $3K from 18 others
What the payments were for
- Consulting fees$4951%
- Speaking & faculty fees$56,32057%
- Grants$9,0009%
- Travel & lodging$12,12412%
- Food & beverage$20,96321%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 318 | $79,559 |
| Boston Scientific | 55 | $7,325 |
| Abbott | 119 | $4,676 |
| Globus Medical | 32 | $2,200 |
| Nevro Corp. | 22 | $1,437 |
| Nalu Medical, Inc. | 24 | $950 |
| Spinal Simplicity, LLC | 21 | $923 |
| Painteq LLC | 16 | $844 |
| Relievant Medsystems, Inc. | 6 | $348 |
| Zynex Medical, Inc. | 1 | $131 |
| AbbVie(2 entities) | 6 | $109 |
| Tersera Therapeutics LLC | 2 | $58 |
| SPR Therapeutics, Inc | 2 | $54 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $54 |
| Radius Health, Inc. | 3 | $49 |
| Vertex | 1 | $44 |
| Amgen | 2 | $39 |
| Vertos Medical, Inc. | 1 | $32 |
| Lundbeck LLC | 1 | $24 |
| Si-bone, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$45,083
- VANTA ADAPTIVESTIM$11,676
- KYPHON EXPRESS II KYPHOPAK TRAY$6,225
- SPECTRA WAVEWRITER$5,000
- SYNCHROMED$4,000
- INTELLIS$2,911
- Senza$2,335
- SYNCHROMEDII$2,104
- PROCLAIM$1,411
- VERTIFLEX SUPERION$792
- HA MINUTEMAN G3-R$596
- OCTRODE$563
- Intracept$300
- Nalu Neurostimulation System$260
- PRIMEADVANCED SURESCAN$185
- SUPERION$150
- RESTORE$150
- Omnia$147
- KYPHON Balloon Kyphoplasty$139
- Nexwave$131
How this compares
$98,932 in reported general payments places this provider in the 95th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 16 | $25,159 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 632 | $18,289 |
| BelbucaBuprenorphine Hcl | 23 | $15,970 |
| Xtampza ErOxycodone Myristate | 29 | $15,646 |
| Pregabalin | 542 | $11,597 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 304 | $8,187 |
| Buprenorphine | 26 | $8,183 |
| Lidocaine | 49 | $6,151 |
| Tramadol Hcl | 377 | $3,664 |
| Gabapentin | 319 | $3,483 |
| Morphine Sulfate ErMorphine Sulfate | 40 | $2,895 |
| Cyclobenzaprine Hcl | 132 | $2,315 |
| Morphine Sulfate | 53 | $2,244 |
| Duloxetine Hcl | 121 | $1,945 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 83 | $1,813 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $16 | $31,61652 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 287 interventional pain medicine providers in Texas.
Other interventional pain medicine in Cedar Park
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.1M
- Chad StephensSouthlake$1M
- Ankur KhoslaShenandoah$277K
- Brian RichDecatur$245K
- Brian BruelHouston$219K
- Bolkar SahinlerLubbock$188K
- Timothy RatinoFort Worth$139K
- Genaro GutierrezAustin$125K
- Thomas WhiteShenandoah$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.